Pancreatic Cancer Research

ResearcherThe University of OsakaNo recent work listed

Suguru Mitsufuji

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5024326886. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2022: 3 papers

Papers 3

  1. N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-15196-5↗
  2. Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-11668-0↗
  3. ASO Author Reflections: A Novel Mechanism of Suppressing Proliferation After Inhibition of Clusterin in Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-11745-4↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuichiro Doki · 3 shared papers, 2022 · strength 0.40
  2. Hidetoshi Eguchi · 3 shared papers, 2022 · strength 0.40
  3. Hirofumi Akita · 3 shared papers, 2022 · strength 0.40
  4. Masahiro Tanemura · 2 shared papers, 2022 · strength 0.27
  5. Tadafumi Asaoka · 2 shared papers, 2022 · strength 0.27
  6. Yoshifumi Iwagami · 2 shared papers, 2022 · strength 0.27
  7. Yoshito Tomimaru · 2 shared papers, 2022 · strength 0.27
  8. Daisaku Yamada · 2 shared papers, 2022 · strength 0.27
  9. Kunihito Gotoh · 2 shared papers, 2022 · strength 0.27
  10. Hidenori Takahashi · 2 shared papers, 2022 · strength 0.27
  11. Kazuki Sasaki · 2 shared papers, 2022 · strength 0.27
  12. Ryota Chijimatsu · 1 shared paper, 2022 · strength 0.14
  13. Kazuhiko Ogawa · 1 shared paper, 2022 · strength 0.14
  14. Shotaro Tatekawa · 1 shared paper, 2022 · strength 0.14
  15. Yoshiki Murakumo · 1 shared paper, 2022 · strength 0.14
  16. Hideshi Ishii · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.